3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Gastrointestinal
2
Conditions
Endometrial Neoplasms
13
Uterine Cervical Neoplasms
4
Ovarian Neoplasms
3
Vulvar Neoplasms
2
Squamous Intraepithelial Lesions
2
Rectal Neoplasms
2
Peritoneal Neoplasms
2
Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Anus Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sezary Syndrome
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Interventions
Fluorouracil
3
Watchful Waiting
2
Observation
2
Cisplatin
2
human papillomavirus vaccine, L1 type 16, 18
1
Transurethral Resection of Prostate
1
Radiotherapy
1
Proctoscopy
1
Papillomavirus Vaccines
1
Mass Screening
1
Light Coagulation
1
Laser Therapy
1
Isotretinoin
1
Interviews as Topic
1
Imiquimod
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
HIV Testing
1
Focus Groups
1
Data Collection
1
Colposcopy
1
Blood Specimen Collection
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Acquired Immunodeficiency Syndrome
×
Observation
×
Gynecologic
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts
NCT02503111
2022-06-13
HPV-SAVE
University Health Network, Toronto
Phase NA
Terminated
71 enrolled